Barcinal, Manuel L.
HRN: 15-60-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/28/2024
06/03/2024
IV
600 Mg
Q 6 Hrs
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes